Target intelligence / Profile preview

Ribosomal L24 domain-containing protein 1 (RSL24D1)

Target
RSL24D1
Molecular classification
Other: Ribosome biogenesis factor, Ribosomal protein homolog, Nucleolar protein
01

Overview

Ribosomal L24 domain-containing protein 1 (RSL24D1) is a highly conserved nucleolar protein essential for the biogenesis of the eukaryotic 60S ribosomal subunit[1][3]. RSL24D1 is analogous to the yeast RLP24 and functions in several steps of large subunit assembly, notably pre-rRNA transcription and processing, and influences global protein synthesis[1][3]. It interacts with the RNA polymerase I subunit RPA194 and the PeBoW complex, coordinating ribosomal RNA production with ribosome assembly[1][4]. While not a classical therapeutic target such as a receptor or enzyme, its critical role in ribosome biogenesis links RSL24D1 to regulation of cell growth, pluripotency maintenance, stress response via p53, and disease states like cancer and familial hypercholesterolemia[1][3]. Depletion disrupts ribosomal assembly, triggers ribosomal stress pathways, and impairs protein synthesis, highlighting its essential cellular function. No known drugs directly target RSL24D1, nor is it considered a standard therapeutic target at this time.

Other names
Probable ribosome biogenesis protein RLP24RSL24D1C15orf15RPL24LMY024HRP-L30-isoL30RPL24TVAS360S ribosomal protein L30 isologHomolog of yeast ribosomal like protein 24My024 protein
02

Mechanism of action

Not targeted pharmacologically. The molecule acts by interacting with the RNA polymerase I complex and other ribosome assembly factors (e.g., PeBoW complex), regulating pre-rRNA transcription and 60S subunit maturation[1][4].

03

Biological functions

Ribosome biogenesis (especially 60S large ribosomal subunit assembly)Pre-rRNA transcription and processingRegulation of global mRNA translationControl of stem cell homeostasis, proliferation, and self-renewalCoordination between ribosome production and chromatin/transcription networks
04

Disease associations

Cancer: Expression changes linked to early stage cancer progressionFamilial hypercholesterolemia: Up-regulation associatedOther: Effects on stem cell fate and stress responses via p53
05

Safety considerations

No available therapeutic targeting data; depletion causes nucleolar disorganization, p53 stabilization, reduction in protein synthesis, potential cell viability loss[1][3].
06

Biomarkers

RSL24D1 expression in "tumor educated platelets" as a negative biomarker for early-stage cancer progressionUp-regulation in familial hypercholesterolemia

Beyond the preview

Go deeper on Ribosomal L24 domain-containing protein 1 (RSL24D1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal L24 domain-containing protein 1 (RSL24D1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call